GlassScriptPhysician profile
Kyle G Thompson
NPI 1710111224
$3,124.72
in general payments reported to CMS, 2019-2025
26 companies · $635 in 2025
The $635 reported for 2025 was more than what a typical Retina Specialist provider received nationally (typical 2025 total: $460).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $437 · 2020: $33.27 · 2021: $182 · 2022: $428 · 2023: $725 · 2024: $683 · 2025: $635.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,044.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,043.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $486.12 | 2019-2025 | Vabysmo, Lucentis, Susvimo |
| Regeneron Healthcare Solutions, INC. | $387.75 | 2019-2025 | Eylea Hd, Eylea |
| Abbvie INC. | $339.03 | 2019-2025 | Ozurdex |
| Bausch & Lomb Americas INC. | $239.01 | 2022-2025 | Stellaris, Stellaris, Envista Envy Iol |
| Astellas Pharma US INC | $214.31 | 2023-2025 | Izervay |
| Coherus Oncology, INC. | $160.62 | 2024 | |
| Apellis Pharmaceuticals, INC. | $152.89 | 2023-2025 | Syfovre |
| Dutch Ophthalmic, USA | $141.41 | 2022-2025 | Eva, Combined Machine, Tissueblue |
| Allergan, INC. | $139.44 | 2019-2021 | |
| Alimera Sciences, INC. | $118.72 | 2019-2024 | Iluvien, Yutiq |
| Cvrx, INC. | $106.72 | 2022-2024 | Barostim Neo System |
| Genentech, INC. | $102.11 | 2023 | Vabysmo |
| Biotissue Holdings INC. | $90.12 | 2019 | |
| New World Medical,INC. | $79.68 | 2022 | |
| Alcon Vision LLC | $58.12 | 2023-2025 | Eysuvis, Constellation |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eyepoint US, INC. | $45.66 | 2021-2023 | |
| Hologic Sales and Service, LLC | $42.38 | 2023 | Coolseal Generator |
| Novartis Pharmaceuticals Corporation | $39.19 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $34.17 | 2019 | |
| Ferring Pharmaceuticals INC. | $29.81 | 2022 | |
| Neurotech Pharmaceuticals, INC. | $24.50 | 2025 | |
| Ani Pharmaceuticals, INC. | $22.57 | 2025 | Yutiq |
| Sight Sciences, INC. | $19.60 | 2021 | |
| Oyster Point Pharma, INC. | $18.32 | 2023 | Tyrvaya |
| Genzyme Corporation | $16.75 | 2019 | |
| Sandoz INC. | $15.72 | 2024 | Cimerli |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.